Stanley Laman Group, Ltd. Abiomed Inc Transaction History

Stanley Laman Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$130.51 - $196.01 $1.45 Million - $2.17 Million	-11,072 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$159.31 - $223.54 $336,303 - $471,892	-2,111 Reduced 16.01%	11,072 $1.89 Million
Q3 2019 Nov 08, 2019	SELL	$175.89 - $279.23 $4,749 - $7,539	-27 Reduced 0.2%	13,183 $2.35 Million
Q2 2019 Aug 01, 2019	BUY	$250.96 - $284.94 $64,998 - $73,799	259 Added 2.0%	13,210 $3.44 Million
Q1 2019 May 10, 2019	SELL	$276.39 - $362.25 $185,457 - $243,069	-671 Reduced 4.93%	12,951 $3.7 Million
Q4 2018 Feb 07, 2019	BUY	$281.08 - $444.25 $3.83 Million - $6.05 Million	13,622 New	13,622 $4.43 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.